Related Experiment Video
Updated: Jul 31, 2026
08:41
Integration of Miniaturized Solid Phase Extraction and LC-MS/MS Detection of 3-Nitrotyrosine in Human Urine for Clinical Applications
Published on: July 14, 2017
Urinary catecholamines and their metabolites in diabetes
Acta Biologica Et Medica Germanica
|January 1, 1975
Summary
Diabetes alters catecholamine metabolism, increasing urinary epinephrine levels. These abnormalities normalize after diabetes treatment, highlighting the link between metabolic control and catecholamine balance.
Area of Science:
- Endocrinology
- Metabolic Research
- Clinical Biochemistry
Background:
- Diabetes mellitus is associated with metabolic dysregulation.
- Catecholamines play crucial roles in physiological processes.
- Previous research suggests potential links between diabetes and altered catecholamine levels.
Purpose of the Study:
- To investigate urinary catecholamine and metabolite levels in diabetic patients.
- To assess changes in catecholamine metabolism before and after diabetes treatment.
- To explore the relationship between diabetes control and catecholamine excretion patterns.
Main Methods:
- Quantification of total, free, and conjugated urinary catecholamines and their metabolites.
- Analysis of samples from diabetic patients before and after therapeutic intervention.
- Comparison of catecholamine excretion in diabetic versus non-diabetic states.
Main Results:
- Significantly increased 24-hour urinary excretion of total catecholamines in diabetics.
- Elevated levels of free, conjugated, and total epinephrine in diabetic patients.
- No significant change in dopamine concentration observed, despite its known role in insulin release.
- No observed sex differences in catecholamine excretion among diabetic patients.
Conclusions:
- Diabetic conditions induce significant abnormalities in catecholamine metabolism and excretion.
- Epinephrine levels are notably increased in individuals with diabetes.
- Successful management of diabetes leads to the normalization of catecholamine metabolism and metabolite levels.
- These findings underscore the impact of glycemic control on the sympathoadrenal system.
More Related Videos
13:35A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites
Published on: March 1, 2018
10:31Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Related Concept Videos
01:29Urine Studies I: Urinalysis
Urinalysis is a widely used diagnostic test that analyzes urine's physical, chemical, and microscopic characteristics. Healthcare providers use it to detect and monitor various health conditions, including renal disease, urinary tract infections (UTIs), diabetes, and metabolic or systemic disorders.Components of UrinalysisUrinalysis consists of three primary components: physical, chemical, and microscopic examination. Each provides unique insights into the urine sample and, by extension, the...
01:29Diabetes Insipidus I: Introduction
Definition Diabetes insipidus is a disorder marked by the production of large amounts of dilute urine because of impaired vasopressin production, release, or kidney response. The lack of effective vasopressin action limits water reabsorption in the renal collecting ducts, which leads to excessive urinary water loss and intense thirst.Clinical PresentationIndividuals with diabetes insipidus report persistent thirst and very high urine output. In severe cases, fluid intake can reach up to 20...
01:22Diabetes Insipidus II: Pathophysiology
Normally, water balance is maintained through three interconnected mechanisms: the hypothalamic thirst center, the synthesis and release of antidiuretic hormone (ADH, or vasopressin), and the kidneys' responsiveness to this hormone. ADH is synthesized in the hypothalamus, released from the posterior pituitary, and acts on the distal nephron, allowing water reabsorption and concentrated urine production.Diabetes Insipidus and Its TypesIn diabetes insipidus (DI), this regulatory system is...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...